Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial to Assess the Effectiveness of a Zinc-containing Vaginal Gel and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis.

NCT05895162 is registered in ClinicalTrials.gov with FEMPHARMA Kft. as lead sponsor.

NCT NCT05895162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05895162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial to Assess the Effectiveness of a Zinc-containing Vaginal Gel and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis.
Lead sponsor
FEMPHARMA Kft.
Phase
Not applicable
Overall status
Completed
Start date
June 10, 2023
Completion date
April 20, 2026
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal yeast infections, vulvovaginal candidiasis